Project Grant R01HL174439
Award Date
7/1/24
Completion Date
6/30/29
Dollars Obligated
$484K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Reno, NV 89557, USA
Similar Awards
This $741,512 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports research on the role of the transcription factor NRF2 in the stellate ganglia and cardiac sympathetic tone in chronic heart failure.
The research, conducted by the University of Nebraska Medical Center, aims to: 1) evaluate the time-course changes in neural inflammation, oxidative stress, and NRF2 signaling in the stellate ganglia after myocardial...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will provide $557,649.00 to the University of Nevada, Reno (UNR) for a 5-year research project. The objective is to investigate the molecular mechanisms underlying the activation of β2 integrins in neutrophils, which play a key role in inflammation and ischemia-reperfusion injury associated with cardiovascular disease. The research aims to...
This federal Project Grant award, with ID R01HL171118, was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The $847,164 award supports research to investigate the mechanistic basis for pathologic remodeling of the ventricular conduction system, particularly focusing on the role of Purkinje cells, in acquired cardiomyopathies such as those seen in patients with hypertension, diabetes, and obesity.
The primary...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $448,968 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Colorado State University in Fort Collins, CO. The grant supports research investigating the mechanisms by which chronic stress impacts cardiovascular function, particularly the role of neural circuits involving the prefrontal cortex and hypothalamus. The project aims to elucidate sex-specific differences in these stress-cardiovascular...
This Project Grant award of $644,687 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research (CFDA 93.837) program supports research aimed at understanding how a hypothalamic-brainstem neural circuit contributes to the adaptive and maladaptive cardiorespiratory responses to chronic intermittent hypoxia (CIH).
The research, conducted by the University of Missouri System, utilizes an integrative approach involving chemogenetic and in vitro...
This Project Grant award, provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to comprehensively characterize the cellular and molecular features of human pulmonary neuroendocrine cells (PNECs), their stem cells, and associated niches. The $1,505,110 award, to be completed by August 31, 2025, will support the use of single-cell RNA sequencing and in situ hybridization techniques to map the...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $717,773 to the Rector & Visitors of the University of Virginia (UVA) to investigate the role of mechanically-sensitive protein complexes involving PANX1 and PIEZO1 channels in regulating renin release, a key process in the renin-angiotensin-aldosterone system (RAAS) that influences blood pressure. The research aims to...
This federal Project Grant award of $620,371 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The grant supports research to determine the voltage-sensing domain (VSD) dynamics of recombinant cyclic nucleotide-binding domain (CNBD) channels, including hyperpolarization-activated cyclic nucleotide-gated (HCN) and depolarization-activated KCNH channels. The research aims to improve the understanding of the...
This $566,357 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research into the role of Protein Tyrosine Phosphatase 1B (PTP1B) in cardiac hypertrophy and heart failure.
The key objectives are to: 1) Determine the molecular mechanisms controlling PTP1B oxidation and downstream thyroid hormone signaling in cardiac hypertrophy, and 2) Investigate the therapeutic and anti-hypertrophic effects...
This federal Project Grant award of $249,000 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support the development of microphysiological systems to study hypoxic cardiac injury. The project aims to engineer microfluidic devices that can precisely control oxygen levels to investigate the molecular pathways and functional effects on cardiomyocytes under oxygen gradients, as observed during myocardial infarction...